Some studies showed a tumor-promoting effect for Notch1 signaling and thus linked it to a poor prognosis in breast cancer (14), gastric cancer (15, 16), as well as NSCLC, and therefore proposed the possible use of Notch inhibitors in cancer treatment (17–19). This evidence concerns the gene NOTCH1 and neoplasm.